Core Viewpoint - The registration application for the self-expanding intracranial drug-eluting stent developed by Xinwei Medical-B (06609.HK) has been accepted by the National Medical Products Administration of the People's Republic of China, indicating a significant advancement in the company's product development [1] Company Summary - Xinwei Medical-B is at the forefront of developing a self-expanding intracranial drug-eluting stent, which is designed for the treatment of intracranial atherosclerotic stenosis [1] - The stent serves to support and open the lumen of narrowed and obstructed arteries, effectively preventing in-stent restenosis [1] Industry Summary - Currently, there are no similar products approved for market release globally, positioning Xinwei Medical-B as a leader in this specific product category within the industry [1]
心玮医疗-B(06609.HK)：自膨式颅内药物洗脱支架的注册申请获国家药监局受理